RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO), a developer of innovative medical technology, today announced that it has reorganized its common stock by a reverse split of one share for each one hundred and fifty (1/150) of issued and outstanding shares as of September 5, 2008. Subsequent to the reverse, there will be approximately 62 million shares of common shares outstanding. In addition the authorized common stock has been reduced to 950 million shares.
